PRO-300

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePRO-300
Drug Alias NameOralXmucositis therapy (ProCertus)PRO-300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMucositis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProcertus Biopharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProcertus Biopharm Inc
Active IndicationsN/A
Inactive IndicationsMucositis

Other Information

ATC CodeN/A
Related LinksN/A